BioStock published an article on 17 June 2020 about Follicum, which can be read in full below. Tomorrow, world-leading diabetes experts and front runners of regional R&D in type 1 diabetes will gather at a free Medicon Valley Alliance webinar. Lund-based Follicum will be among the participants, and BioStock has talked to CEO Jan Alenfall […]
BioStock published an article on 12 May 2020 about Follicum, which can be read in full below. The peptide specialist company Follicum has filed an international patent application for its topical cream formulation. The application is both relevant for the company’s furthest-advanced candidate, FOL-005, which is currently undergoing a clinical phase IIa study in hair […]
BioStock published an article on 27 April 2020 about hair loss and Follicum, which can be read in full below. Hair loss is a benign condition with limited physical effects, but the psychosocial aspects are more severe. Hair is a key part of our self-image and self-expression, aspects that can be ruthlessly squashed by hair […]
BioStock published an article on 25 March 2020 about Follicum, which can be read in full below. Follicum’s diabetes project took a big leap forward last Friday with a preliminary patent approval from the European Patent Office regarding the company’s diabetes peptides. BioStock contacted CEO Jan Alenfall to find out more about the project, the patent […]
BioStock published an article on 9 March 2020 about female alopecia, which can be read in full below. Hair loss is common, and, while it does not necessarily come with any serious health complications, the stigma can be debilitating. This is especially true in women, who are often neglected in the discussions around alopecia. On […]
BioStock published an article on 4 February 2020 about Follicum, which can be read in full below. FOL-005, Follicum’s hair growth candidate, has received approval from German authorities to initiate a phase IIa study. Patient recruitment will commence shortly, and initial results are expected before the end of the year. The company’s aim is to then […]
BioStock published an article on 20 January 2020 about Follicum, which can be read in full below. Pharmaceutical drugs are often subdivided into two fractions: small molecules and large molecules (or biologics). However, a third category called peptides falls right in-between, thus generating an overlap of benefits from the other classes of molecules. Follicum’s two projects, […]
BioStock published an article on 18 December 2019 about Follicum, which can be read in full below. Both of Follicum’s projects, FOL-005 and the diabetes peptides, have reached important milestones this year. A topical formulation of the company’s hair loss treatment has successfully completed toxicology and safety profile clinical studies, and Follicum is all set […]
BioStock published an article on 17 December 2019 about Follicum, which can be read in full below. Yesterday, Follicum received a formal patent approval from the US Patent and Trademark Office protecting the hair project FOL-005 through 2032. In addition, the Lund-based company runs a diabetes project where previous preclinical studies have shown an ability […]
BioStock published an article on 6 December 2019 about Follicum, which can be read in full below. The competition within the therapeutic arena related to hair loss is limited as no new treatments have been registered during the last 25 years. However, the field got a big jolt last month as Irish big pharma giant […]